n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline has been researched along with pyridoxine in 2 studies
*Pyridoxine: The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). [MeSH]
*Pyridoxine: The 4-methanol form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). [MeSH]
| Studies (n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline) | Trials (n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline) | Recent Studies (post-2010) (n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline) | Studies (pyridoxine) | Trials (pyridoxine) | Recent Studies (post-2010) (pyridoxine) |
|---|---|---|---|---|---|
| 14 | 0 | 3 | 7,831 | 466 | 637 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asao, T; Katunuma, N; Tsuge, H | 1 |
| Katunuma, N | 1 |
2 review(s) available for n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline and pyridoxine
| Article | Year |
|---|---|
[Development of new specific inhibitors for cathepsins and its application for medical field].
Topics: Animals; Cathepsins; Crystallography, X-Ray; Dipeptides; Drug Design; Molecular Conformation; Propionates; Pyridoxine | 2000 |
[Structure-based drug development and medical/biological application of cathepsin specific inhibitors].
Topics: Antigen Presentation; Autoantigens; Bone Neoplasms; Cathepsins; Dipeptides; Drug Design; Epoxy Compounds; Humans; Lysosomes; Osteoporosis; Propionates; Protein Conformation; Pyridines; Pyridoxine; Receptor, Insulin; Sjogren's Syndrome | 2009 |